Navigation Links
Monogram Announces 2008 Third Quarter Financial Results
Date:10/27/2008

- 11,828

Accounts receivable, net 16,019 9,100

Prepaid expenses 1,273 1,279

Inventory 1,460 1,250

Other current assets 879 917

Total current assets 41,462 43,136

Property and equipment, net 7,824 7,665

Goodwill 9,927 9,927

Deferred costs 15,122 8,043

Other assets 43 540

Total assets $74,378 $69,311

LIABILITIES AND STOCKHOLDERS' DEFICIT

Current liabilities:

Accounts payable $2,110 $2,116

Accrued compensation 5,959 3,324

Accrued liabilities 4,121 3,818

Current portion of restructuring costs 458 610

Deferred revenue, current portion 853 605

Current portion of loans payable and

capital lease obligations 10,151 4,469

Contingent value rights 2,060 2,119

Total current liabilities 25,712 17,061

Long-term 3% convertible promissory note 19,826 20,786

Long-term 0% convertible promissory note 13,171 18,511

Long-term portion of restructuring costs - 289

Long-term deferred revenue 23,771 13,622

Other long-term liabilities 843 282

Total liabiliti
'/>"/>

SOURCE Monogram Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
2. Monogram Biosciences to Present at the ThinkEquity Partners Fifth Annual Growth Conference
3. Monogram Biosciences to Present at the JMP Securities Healthcare Conference
4. Monogram Biosciences Announces Third Quarter 2007 Financial Results Conference Call
5. Monogram Announces Third Quarter 2007 Financial Results
6. Monogram Biosciences to Present at the Piper Jaffray 19th Annual Healthcare Conference
7. Monogram Biosciences Announces Fourth Quarter 2007 Financial Results Conference Call
8. Data Presented on Monogram HIV Tropism Tests at Retrovirus Conference sets New Standards of Assay Sensitivity
9. Monogram Biosciences and Avexa Announce Exclusive Collaboration to Support New HIV Drug Discovery and Development Efforts
10. Monogram Announces Promotion of Gordon Parry, PhD, to Vice President, Research and Development, Oncology
11. Monogram HIV Antibody Assay Is Key Component of Innovative Vaccine Development Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... 1, 2015 InferMed , ... will ... evidence-based clinical s olutions suite   ... information products and services, announced today the acquisition of  InferMed ... (CDS) technology company. InferMed,s Arezzo technology supports clinicians ...
(Date:7/1/2015)...  UCB, a multinational biopharmaceutical company, and Genpact ... designing, transforming, and running intelligent business operations, have ... their close collaboration in driving transformation that achieved ... (GBS) finance organization. The Aecus Innovation ... together effectively to embrace the innovative promise of ...
(Date:6/30/2015)... , June 30, 2015 /PRNewswire/ - Resverlogix ... of common shares of Resverlogix have approved the ... Eastern Capital Limited of 5,600,000 units at a ... Placement"), each unit being comprised of one common ... aggregate proceeds of approximately CAD$15 million; and (ii) ...
(Date:6/30/2015)... June 30, 2015  Juniper Pharmaceuticals, Inc. (Nasdaq: ... developing therapeutics that address unmet medical needs in ... Elston will present at the Cantor Fitzgerald ... 8, 2015Time: , 4:45 PM EDTLocation: , Le ... archive): , www.juniperpharma.com, under  ,Investor, or  ...
Breaking Biology Technology:Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 2Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 3Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 4UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 2UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 3UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 4UCB and Genpact Receive Aecus Innovation Award for Success in Global Business Services 5Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 2Resverlogix Corp. Shareholders Approve Matters Relating to Licensing and Equity Arrangement 3Juniper Pharmaceuticals to Present at Cantor Fitzgerald Inaugural Healthcare Conference on July 8, 2015 2
... July 1 Liko, a major supplier of,patient ... industry,has announced two new additions to its "Stat" ... Both new products, the Stat HandySheet(TM) and the ... patients or the movement of,patients in bed., ...
... (67%) of Americans are generally concerned about ... according to a 2008 National Consumer Water ... warning of contaminants1 (i.e. lead, radium, chlorine) ... controversy and confusion. Consumers are also learning ...
... July 1 Neogen Corporation,(Nasdaq: NEOG ) ... line used in,animal health and hygiene applications from ... 14 different product formulations,along with manufacturing process know-how ... were not disclosed., The addition of these ...
Cached Biology Technology:Liko Introduces Two Additions to Its 'Stat' Family of Low Friction Sheets 2 Culligan's New Aqua-Cleer Advanced Drinking Water SystemProvides Clean, Quality Water Customized for Every Home 2 Culligan's New Aqua-Cleer Advanced Drinking Water SystemProvides Clean, Quality Water Customized for Every Home 3Neogen Acquires Product Line From DuPont Animal Health Solutions 2
(Date:6/24/2015)... -- The biologics safety testing market is growing at ... include growth of the pharmaceutical and biological industries and ... years, the number of drug approvals in North American ... approved 225 drug applications and Health Canada approved 99. ... accounted for 3,822 of the pharmaceutical and 1,998 ...
(Date:6/24/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/hhwlfj/huawei_ascend ... "Huawei Ascend Mate 7 Fingerprint Sensor - Reverse ... Huawei,s technological choice for the fingerprint sensor ... and Samsung,s one. The Ascend Mate 7 presents ... a main actor in capacitive sensing human interface ...
(Date:6/23/2015)... 2015 Research and ... the "Body-Worn Temperature Sensors Market - Global ... 2014 - 2020" report to their offering. ... the global body-worn temperature sensors market. The global ... the basis of types, care setting, patient demographic, ...
Breaking Biology News(10 mins):Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4Huawei Ascend Mate 7 Fingerprint Sensor - Reverse Costing Analysis 2Body-Worn Temperature Sensors Market - Global Industry Analysis 2
... USC have unlocked the mystery of why new cases of ... that causes the disease disproportionately increases a normal father,s production ... Noonan syndrome mutation arises in a normal sperm stem cell ... stem cells lacking the mutation. The father then is more ...
... , June 6, 2013 Research and ... the "DNA Microarray 2013: A Focus on Sales ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , ,DNA Microarray 2013 presents the ... involving the participation of 201 buyers and end-users in ...
... a new field in medicine curing diseases by replacing ... artificial limb replaces the function of a leg or arm ... science on the cusp of chemistry and biology who focuses ... water. They will deliver the next talks in the ...
Cached Biology News:DNA Microarray 2013 Market Report: A Focus on Sales Growth 2Medicine, energy topics of Kavli lectures at American Chemical Society meeting 2Medicine, energy topics of Kavli lectures at American Chemical Society meeting 3
...
Pronase Reagent...
CircuLex Anti-Human S100P Polyclonal Antibody Research Focus: proliferation Storage: -20C Shipping Temperature: 4C...
Rabbit polyclonal to ECSIT ( Abpromise for all tested applications). entrezGeneID: 51295 SwissProtID: Q96HQ7...
Biology Products: